Contact allergy to bufexamac.
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003877:Dermatitis, Contact / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D005260:Female; D006801:Humans; D006877:Hydroxamic Acids / Q000009:adverse effects* / Q000627:therapeutic use; D010648:Phenylacetates / Q000009:adverse effects / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D011539:Pruritus Vulvae / Q000188:drug therapy; D012882:Skin Tests
D000893:Anti-Inflammatory Agents; D006877:Hydroxamic Acids; D010648:Phenylacetates; D011241:Prednisone